Quellen:
von Lewinski, Dirk et al. “Empagliflozin in acute Myocardial Infarction: the EMMY trial.” European heart journal, ehac494. 29 Aug. 2022, doi:10.1093/eurheartj/ehac494
https://pubmed.ncbi.nlm.nih.gov/36036746/
Butler, Javed et al. “Patiromer for the management of hyperkalaemia in patients receiving renin-angiotensin-aldosterone system inhibitors for heart failure: design and rationale of the DIAMOND trial.” European journal of heart failure vol. 24,1 (2022): 230-238. doi:10.1002/ejhf.2386
https://pubmed.ncbi.nlm.nih.gov/34800079/